April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Diabetes Upregulates P-Selectin Glycoprotein Ligand-1 (PSGL-1) Function
Author Affiliations & Notes
  • L. Almulki
    Department of Ophthalmology, Angiogenesis Lab, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • K. Noda
    Department of Ophthalmology, Angiogenesis Lab, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • F. Tayyari
    Department of Ophthalmology, Angiogenesis Lab, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • S. A. Frimmel
    Department of Ophthalmology, Angiogenesis Lab, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • S. Zandi
    Department of Ophthalmology, Angiogenesis Lab, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • S. Nakao
    Department of Ophthalmology, Angiogenesis Lab, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • V. de Arce
    Department of Ophthalmology, Angiogenesis Lab, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • A. Hafezi-Moghadam
    Department of Ophthalmology, Angiogenesis Lab, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  L. Almulki, None; K. Noda, None; F. Tayyari, None; S.A. Frimmel, None; S. Zandi, None; S. Nakao, None; V. de Arce, None; A. Hafezi-Moghadam, None.
  • Footnotes
    Support  NIH grants HL086933 and AI050775, Massachusetts Lions Eye Research Fund Inc., Marion W. and Edward F. Knight AMD Fund, and Research to Prevent Blindness.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 14. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Almulki, K. Noda, F. Tayyari, S. A. Frimmel, S. Zandi, S. Nakao, V. de Arce, A. Hafezi-Moghadam; Diabetes Upregulates P-Selectin Glycoprotein Ligand-1 (PSGL-1) Function. Invest. Ophthalmol. Vis. Sci. 2009;50(13):14. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Capillary occlusion due to leukocyte-endothelial interaction is considered a critical early event in diabetic retinopathy (DR). However, little is known about changes in leukocytes surface molecules during disease. Here, we investigate the expression and function of PSGL-1, the principal rolling ligand of endothelial P-selectin, in experimental diabetes.

Methods: : Diabetes was induced in 150-175mg male Long Evans rats by intraperitoneal injection of 60mg/kg streptozotocin. To investigate leukocyte PSGL-1 on a functional level during diabetes, we utilized our autoperfused micro flow chamber (0.4x0.04mm), coated with 5µg/ml recombinant P-selectin. Blood flow through the chamber allows live microscopy of leukocyte interaction with the immobilized P-selectin. The inlet blood pressure was kept at 40mmHg (18.7dyne/cm2). Leukocyte rolling velocity in the chambers was quantified in 4wks diabetic rats and controls. Furthermore, PSGL-1 expression in peripheral blood leukocytes (PBLs) was analyzed in flow cytometry, using soluble recombinant P-selectin Fc fusion protein (1µg/106) and a secondary FITC-labeled anti-human Fc mAb for staining.

Results: : Leukocyte rolling velocity on immobilized P-selectin was significantly reduced by 51.7% in 4wks diabetic animals (1.4±0.02µm/s) compared to normal controls (2.9±0.42µm/s, n=4 each, p<0.05). Flow cytometry revealed an 11% increase in mean fluorescence intensity (MFI) of PSGL-1 on PBLs of diabetic rats (89.9, n=5) compared to controls (79, n=4).

Conclusions: : Diabetes causes reduced PSGL-1/P-selectin mediated leukocyte-rolling velocity. Our data provide direct evidence for functional PSGL-1 upregulation in experimental diabetes. This novel finding advances our understanding of molecular and cellular events that precede leukostasis and capillary occlusion in DR.

Keywords: diabetes • inflammation • vascular occlusion/vascular occlusive disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×